Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna S Yi

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Pediatrics|April 15, 2009
Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantationJoanna S Yi, Christopher L Moertel, K Scott Baker
Journal of Pediatric Hematology/Oncology|December 7, 2013
A novel APC gene mutation associated with a severe phenotype in a patient with Turcot syndromeStephanie A Fritch Lilla, Joanna S Yi, Beth A C Hall, et al.
Pediatric Blood & Cancer|November 19, 2016
Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment planJoanna S Yi, Junne Kamihara, Jennifer C Kesselheim, et al.
Human Mutation|February 15, 2022
Novel CIC variants identified in individuals with neurodevelopmental phenotypesSaloni Sharma, Brenna Hourigan, Zain Patel, et al.
Scientific Reports|July 6, 2016
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activityZhenghu Chen, Zhenyu Wang, Jonathan C Pang, et al.
Cell Stem Cell|February 2, 2022
An oncogenic enhancer encodes selective selenium dependency in AMLKenneth Eagle, Yajian Jiang, Xiangguo Shi, et al.
Nature Communications|October 30, 2024
MLL oncoprotein levels influence leukemia lineage identitiesDerek H Janssens, Melodie Duran, Dominik J Otto, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
KMT2A oncoproteins induce epigenetic resistance to targeted therapiesDerek H Janssens, Melodie Duran, Dominik J Otto, et al.
Oncotarget|October 21, 2016
Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastomaJiaxiong Lu, Shan Guan, Yanling Zhao, et al.
Oncotarget|December 22, 2017
Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth <i>in vivo</i>Zhenghu Chen, Yanling Zhao, Yang Yu, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Pediatrics|April 15, 2009
Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantationJoanna S Yi, Christopher L Moertel, K Scott Baker
Journal of Pediatric Hematology/Oncology|December 7, 2013
A novel APC gene mutation associated with a severe phenotype in a patient with Turcot syndromeStephanie A Fritch Lilla, Joanna S Yi, Beth A C Hall, et al.
Pediatric Blood & Cancer|November 19, 2016
Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment planJoanna S Yi, Junne Kamihara, Jennifer C Kesselheim, et al.
Human Mutation|February 15, 2022
Novel CIC variants identified in individuals with neurodevelopmental phenotypesSaloni Sharma, Brenna Hourigan, Zain Patel, et al.
Scientific Reports|July 6, 2016
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activityZhenghu Chen, Zhenyu Wang, Jonathan C Pang, et al.
Cell Stem Cell|February 2, 2022
An oncogenic enhancer encodes selective selenium dependency in AMLKenneth Eagle, Yajian Jiang, Xiangguo Shi, et al.
Nature Communications|October 30, 2024
MLL oncoprotein levels influence leukemia lineage identitiesDerek H Janssens, Melodie Duran, Dominik J Otto, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
KMT2A oncoproteins induce epigenetic resistance to targeted therapiesDerek H Janssens, Melodie Duran, Dominik J Otto, et al.
Oncotarget|October 21, 2016
Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastomaJiaxiong Lu, Shan Guan, Yanling Zhao, et al.
Oncotarget|December 22, 2017
Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth <i>in vivo</i>Zhenghu Chen, Yanling Zhao, Yang Yu, et al.
Pageof 3